Pyruvate Kinase Activity Regulates Cystine Starvation Induced Ferroptosis through Malic Enzyme 1 in Pancreatic Cancer Cells

Pancreatic ductal adenocarcinoma (PDAC) is an aggressive cancer with high mortality and limited efficacious therapeutic options. PDAC cells undergo metabolic alterations to survive within a nutrient-depleted tumor microenvironment. One critical metabolic shift in PDAC cells occurs through altered isoform expression of the glycolytic enzyme, pyruvate kinase (PK). Pancreatic cancer cells preferentially upregulate pyruvate kinase muscle isoform 2 isoform (PKM2). PKM2 expression reprograms many metabolic pathways, but little is known about its impact on cystine metabolism. Cystine metabolism is critical for supporting survival through its role in defense against ferroptosis, a non-apoptotic iron-dependent form of cell death characterized by unchecked lipid peroxidation. To improve our understanding of the role of PKM2 in cystine metabolism and ferroptosis in PDAC, we generated PKM2 knockout (KO) human PDAC cells. Fascinatingly, PKM2KO cells demonstrate a remarkable resistance to cystine starvation mediated ferroptosis. This resistance to ferroptosis is caused by decreased PK activity, rather than an isoform-specific effect. We further utilized stable isotope tracing to evaluate the impact of glucose and glutamine reprogramming in PKM2KO cells. PKM2KO cells depend on glutamine metabolism to support antioxidant defenses against lipid peroxidation, primarily by increased glutamine flux through the malate aspartate shuttle and utilization of ME1 to produce NADPH. Ferroptosis can be synergistically induced by the combination of PKM2 activation and inhibition of the cystine/glutamate antiporter in vitro. Proof-of-concept in vivo experiments demonstrate the efficacy of this mechanism as a novel treatment strategy for PDAC. Graphical Abstract Highlights PKM2KO in pancreatic ductal adenocarcinoma (PDAC) cells produces enhanced defense against cystine starvation induced ferroptosis. Pharmacologic activation of pyruvate kinase (PK) activity promotes ferroptosis under cystine starvation, while inhibition promotes ferroptosis survival in PDAC cells. Decrease in PK activity reprograms glutamine metabolism to increase use of malic enzyme 1 and promote survival under cystine starvation in PDAC cells. Cystine starvation and activation of pyruvate kinase synergistically decreases progression of pancreatic cancer in vivo.

[1]  Qing Yang,et al.  c-Myc protects hepatocellular carcinoma cell from ferroptosis induced by glutamine deprivation via upregulating GOT1 and Nrf2 , 2023, Molecular Biology Reports.

[2]  Kellen L. Olszewski,et al.  SLC7A11 expression level dictates differential responses to oxidative stress in cancer cells , 2023, Nature communications.

[3]  D. Pratt,et al.  Ferroptosis: A flexible constellation of related biochemical mechanisms. , 2023, Molecular cell.

[4]  J. Yang,et al.  Malic Enzyme 1 as a Novel Anti‐Ferroptotic Regulator in Hepatic Ischemia/Reperfusion Injury , 2023, Advanced science.

[5]  Xianjun Yu,et al.  Glutamine deprivation induces ferroptosis in pancreatic cancer cells , 2023, Acta biochimica et biophysica Sinica.

[6]  Yaming Li,et al.  Upstream stimulatory factor 2 inhibits erastin-induced ferroptosis in pancreatic cancer through transcriptional regulation of pyruvate kinase M2. , 2022, Biochemical pharmacology.

[7]  C. Porta,et al.  Efficacy and Safety of Telaglenastat Plus Cabozantinib vs Placebo Plus Cabozantinib in Patients With Advanced Renal Cell Carcinoma: The CANTATA Randomized Clinical Trial. , 2022, JAMA oncology.

[8]  B. Stockwell.  Ferroptosis turns 10: Emerging mechanisms, physiological functions, and therapeutic applications , 2022, Cell.

[9]  Jiping Zeng,et al.  Wnt/beta-catenin signaling confers ferroptosis resistance by targeting GPX4 in gastric cancer , 2022, Cell Death & Differentiation.

[10]  Yang Xu,et al.  Rho family GTPase 1 (RND1), a novel regulator of p53, enhances ferroptosis in glioblastoma , 2022, Cell & bioscience.

[11]  L. Wood,et al.  Pancreatic Cancer: Pathogenesis, Screening, Diagnosis and Treatment. , 2022, Gastroenterology.

[12]  Dorett I Odoni,et al.  MYCN mediates cysteine addiction and sensitizes neuroblastoma to ferroptosis , 2022, Nature Cancer.

[13]  K. Suhre,et al.  Advancing Cancer Treatment by Targeting Glutamine Metabolism—A Roadmap , 2022, Cancers.

[14]  Nupur K. Das,et al.  GOT1 inhibition promotes pancreatic cancer cell death by ferroptosis , 2021, Nature Communications.

[15]  C. Kung,et al.  The pyruvate kinase activator mitapivat reduces hemolysis and improves anemia in a β-thalassemia mouse model. , 2021, The Journal of clinical investigation.

[16]  A. Kimmelman,et al.  Harnessing metabolic dependencies in pancreatic cancers , 2021, Nature Reviews Gastroenterology & Hepatology.

[17]  A. Masamune,et al.  Nrf2 Activation Sensitizes K-Ras Mutant Pancreatic Cancer Cells to Glutaminase Inhibition , 2021, International journal of molecular sciences.

[18]  D. Tang,et al.  Characteristics and Biomarkers of Ferroptosis , 2021, Frontiers in Cell and Developmental Biology.

[19]  Xiaowei Liu,et al.  Pyruvate Kinase M2 Coordinates Metabolism Switch between Glycolysis and Glutaminolysis in Cancer Cells , 2020, iScience.

[20]  T. Shlomi,et al.  Mind your media , 2020, Nature Metabolism.

[21]  L. Zhuang,et al.  Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy , 2020, Protein & Cell.

[22]  S. Kuge,et al.  Comprehensive analyses of the cysteine thiol oxidation of PKM2 reveals the effects of multiple oxidation on cellular oxidative stress response , 2020, bioRxiv.

[23]  J. Pouysségur,et al.  Cysteine Depletion, a Key Action to Challenge Cancer Cells to Ferroptotic Cell Death , 2020, Frontiers in Oncology.

[24]  Stephen A. Sastra,et al.  Cysteine depletion induces pancreatic tumor ferroptosis in mice , 2020, Science.

[25]  Christian M. Metallo,et al.  Cystine transporter regulation of pentose phosphate pathway dependency and disulfide stress exposes a targetable metabolic vulnerability in cancer , 2020, Nature Cell Biology.

[26]  A. Vazquez,et al.  Cysteine catabolism and the serine biosynthesis pathway support pyruvate production during pyruvate kinase knockdown in pancreatic cancer cells , 2019, Cancer & Metabolism.

[27]  C. Pereira,et al.  Is immunotherapy the holy grail for pancreatic cancer? , 2019, Immunotherapy.

[28]  D. Tuveson,et al.  Glutamine Anabolism Plays a Critical Role in Pancreatic Cancer by Coupling Carbon and Nitrogen Metabolism , 2019, Cell reports.

[29]  Ze Zhang,et al.  PKM2, function and expression and regulation , 2019, Cell & Bioscience.

[30]  B. Stockwell,et al.  Imidazole Ketone Erastin Induces Ferroptosis and Slows Tumor Growth in a Mouse Lymphoma Model. , 2019, Cell chemical biology.

[31]  John G Doench,et al.  Deubiquitinases Maintain Protein Homeostasis and Survival of Cancer Cells upon Glutathione Depletion. , 2019, Cell metabolism.

[32]  G. DeNicola,et al.  The Non-Essential Amino Acid Cysteine Becomes Essential for Tumor Proliferation and Survival , 2019, Cancers.

[33]  B. Stockwell,et al.  The Hallmarks of Ferroptosis , 2019, Annual Review of Cancer Biology.

[34]  Yongneng Zhang,et al.  Tissue-specific regulation of p53 by PKM2 is redox dependent and provides a therapeutic target for anthracycline-induced cardiotoxicity , 2019, Science Translational Medicine.

[35]  Minghui Gao,et al.  Role of Mitochondria in Ferroptosis. , 2019, Molecular cell.

[36]  M. V. Vander Heiden,et al.  Quantification of microenvironmental metabolites in murine cancers reveals determinants of tumor nutrient availability , 2018, bioRxiv.

[37]  G. Ying,et al.  PKM2 promotes reductive glutamine metabolism , 2018, Cancer biology & medicine.

[38]  S. Teoh,et al.  Measuring the Nutrient Metabolism of Adherent Cells in Culture. , 2018, Methods in molecular biology.

[39]  Harita Dharaneeswaran,et al.  Endothelial pyruvate kinase M2 maintains vascular integrity , 2018, The Journal of clinical investigation.

[40]  He Xiaoyu,et al.  The mTOR Pathway Regulates PKM2 to Affect Glycolysis in Esophageal Squamous Cell Carcinoma , 2018, Technology in cancer research & treatment.

[41]  R. Katakura,et al.  PKM1 Confers Metabolic Advantages and Promotes Cell-Autonomous Tumor Cell Growth. , 2018, Cancer cell.

[42]  K. Yamaguchi,et al.  Pyruvate kinase type M2 contributes to the development of pancreatic ductal adenocarcinoma by regulating the production of metabolites and reactive oxygen species. , 2018, International journal of oncology.

[43]  Chun-you Wang,et al.  The responsively decreased PKM2 facilitates the survival of pancreatic cancer cells in hypoglucose , 2018, Cell Death & Disease.

[44]  M. V. Vander Heiden,et al.  Environmental cystine drives glutamine anaplerosis and sensitizes cancer cells to glutaminase inhibition , 2017, eLife.

[45]  Wei Li,et al.  The glutamate/cystine antiporter SLC7A11/xCT enhances cancer cell dependency on glucose by exporting glutamate , 2017, The Journal of Biological Chemistry.

[46]  Prashant Mishra,et al.  The glutamate/cystine xCT antiporter antagonizes glutamine metabolism and reduces nutrient flexibility , 2017, Nature Communications.

[47]  C. Lyssiotis,et al.  Employing Metabolism to Improve the Diagnosis and Treatment of Pancreatic Cancer. , 2017, Cancer cell.

[48]  T. Jacks,et al.  PKM2, cancer metabolism, and the road ahead , 2016, EMBO reports.

[49]  G. Georgiou,et al.  Systemic depletion of serum l-Cyst(e)ine with an engineered human enzyme induces production of reactive oxygen species and suppresses tumor growth in mice , 2016, Nature medicine.

[50]  M. Belvin,et al.  Metabolic plasticity underpins innate and acquired resistance to LDHA inhibition. , 2016, Nature chemical biology.

[51]  R. Gibbs,et al.  Genomic analyses identify molecular subtypes of pancreatic cancer , 2016, Nature.

[52]  M. Ye,et al.  Pyruvate Kinase M2 Activates mTORC1 by Phosphorylating AKT1S1 , 2016, Scientific Reports.

[53]  C. Thompson,et al.  The Emerging Hallmarks of Cancer Metabolism. , 2016, Cell metabolism.

[54]  B. Stockwell,et al.  Incorporation of metabolically stable ketones into a small molecule probe to increase potency and water solubility. , 2015, Bioorganic & medicinal chemistry letters.

[55]  C. Heeschen,et al.  MYC/PGC-1α Balance Determines the Metabolic Phenotype and Plasticity of Pancreatic Cancer Stem Cells. , 2015, Cell metabolism.

[56]  Jen Jen Yeh,et al.  Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma , 2015, Nature Genetics.

[57]  Anneleen Daemen,et al.  Metabolite profiling stratifies pancreatic ductal adenocarcinomas into subtypes with distinct sensitivities to metabolic inhibitors , 2015, Proceedings of the National Academy of Sciences.

[58]  Minghui Gao,et al.  Glutaminolysis and Transferrin Regulate Ferroptosis. , 2015, Molecular cell.

[59]  R. Deberardinis,et al.  MCT4 defines a glycolytic subtype of pancreatic cancer with poor prognosis and unique metabolic dependencies. , 2014, Cell reports.

[60]  William J. Israelsen,et al.  Pyruvate kinase isoform expression alters nucleotide synthesis to impact cell proliferation. , 2014, Molecular cell.

[61]  Benjamin D. Smith,et al.  Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. , 2014, Cancer research.

[62]  Y. Shah,et al.  Hypoxia-inducible factors link iron homeostasis and erythropoiesis. , 2014, Gastroenterology.

[63]  Jennifer B Dennison,et al.  Antitumor Activity of the Glutaminase Inhibitor CB-839 in Triple-Negative Breast Cancer , 2014, Molecular Cancer Therapeutics.

[64]  Feng Zhang,et al.  Genome engineering using CRISPR-Cas9 system. , 2015, Methods in molecular biology.

[65]  Jie Li,et al.  PKM2 Isoform-Specific Deletion Reveals a Differential Requirement for Pyruvate Kinase in Tumor Cells , 2013, Cell.

[66]  Weiwei Yang,et al.  Nuclear PKM2 regulates the Warburg effect , 2013, Cell cycle.

[67]  Ralph J DeBerardinis,et al.  Glutamine and cancer: cell biology, physiology, and clinical opportunities. , 2013, The Journal of clinical investigation.

[68]  John M. Asara,et al.  Glutamine supports pancreatic cancer growth through a Kras-regulated metabolic pathway , 2013, Nature.

[69]  K. Aldape,et al.  ERK1/2-dependent phosphorylation and nuclear translocation of PKM2 promotes the Warburg effect , 2012, Nature Cell Biology.

[70]  Christian M. Metallo,et al.  Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis , 2012, Nature chemical biology.

[71]  M. R. Lamprecht,et al.  Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death , 2012, Cell.

[72]  Jean-Charles Portais,et al.  IsoCor: correcting MS data in isotope labeling experiments , 2012, Bioinform..

[73]  Michelle F Clasquin,et al.  LC-MS data processing with MAVEN: a metabolomic analysis and visualization engine. , 2012, Current protocols in bioinformatics.

[74]  K. Aldape,et al.  Nuclear PKM2 regulates β-catenin transactivation upon EGFR activation , 2011, Nature.

[75]  Jason W. Locasale,et al.  Inhibition of Pyruvate Kinase M2 by Reactive Oxygen Species Contributes to Cellular Antioxidant Responses , 2011, Science.

[76]  M. V. Vander Heiden,et al.  Aerobic glycolysis: meeting the metabolic requirements of cell proliferation. , 2011, Annual review of cell and developmental biology.

[77]  S. Mazurek.  Pyruvate kinase type M2: a key regulator of the metabolic budget system in tumor cells. , 2011, The international journal of biochemistry & cell biology.

[78]  Matthew K. Knabel,et al.  Pyruvate Kinase M2 Is a PHD3-Stimulated Coactivator for Hypoxia-Inducible Factor 1 , 2011, Cell.

[79]  P. Spellman,et al.  Subtypes of Pancreatic Ductal Adenocarcinoma and Their Differing Responses to Therapy , 2011, Nature Medicine.

[80]  H. Schumny,et al.  Next Generation , 2020 .

[81]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[82]  Ming-Rong Wang,et al.  Mammalian target of rapamycin up-regulation of pyruvate kinase isoenzyme type M2 is critical for aerobic glycolysis and tumor growth , 2011, Proceedings of the National Academy of Sciences.

[83]  Joshua D Rabinowitz,et al.  Metabolomic analysis and visualization engine for LC-MS data. , 2010, Analytical chemistry.

[84]  Jing Chen,et al.  Tyrosine Phosphorylation Inhibits PKM2 to Promote the Warburg Effect and Tumor Growth , 2009, Science Signaling.

[85]  L. Cantley,et al.  Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation , 2009, Science.

[86]  C. Winterbourn,et al.  Thiol chemistry and specificity in redox signaling. , 2008, Free radical biology & medicine.

[87]  J. Rathmell,et al.  New roles for pyruvate kinase M2: working out the Warburg effect. , 2008, Trends in biochemical sciences.

[88]  Ru Wei,et al.  The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth , 2008, Nature.

[89]  V. Nizet,et al.  Role of the hypoxia inducible factors HIF in iron metabolism , 2008, Cell cycle.

[90]  R. Deberardinis,et al.  Beyond aerobic glycolysis: Transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis , 2007, Proceedings of the National Academy of Sciences.

[91]  H. Senn,et al.  Probabilistic quotient normalization as robust method to account for dilution of complex biological mixtures. Application in 1H NMR metabonomics. , 2006, Analytical chemistry.

[92]  O. Warburg.  [Origin of cancer cells]. , 1956, Oncologia.

[93]  Christian M. Metallo,et al.  Oncogenic K-Ras decouples glucose and glutamine metabolism to support cancer cell growth , 2013 .

[94]  Cancer Facts & Figures 2021 , 2010 .